SANOFI (1SAN.MI) Stock Fundamental Analysis
Europe - BIT:1SAN - FR0000120578 - Common Stock
86.13 EUR
+2.09 (+2.49%)
Overall 1SAN gets a fundamental rating of 6 out of 10. We evaluated 1SAN against 53 industry peers in the Pharmaceuticals industry. 1SAN has an excellent profitability rating, but there are some minor concerns on its financial health. 1SAN has a correct valuation and a medium growth rate. Finally 1SAN also has an excellent dividend rating. With these ratings, 1SAN could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
In the past year 1SAN was profitable.
In the past year 1SAN had a positive cash flow from operations.
Each year in the past 5 years 1SAN has been profitable.
Each year in the past 5 years 1SAN had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 11.05%, 1SAN is doing good in the industry, outperforming 75.47% of the companies in the same industry.
1SAN has a Return On Equity of 19.73%. This is in the better half of the industry: 1SAN outperforms 66.04% of its industry peers.
With a decent Return On Invested Capital value of 13.84%, 1SAN is doing good in the industry, outperforming 71.70% of the companies in the same industry.
1SAN had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 15.19%.
The last Return On Invested Capital (13.84%) for 1SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN has a Profit Margin of 20.35%. This is in the better half of the industry: 1SAN outperforms 77.36% of its industry peers.
In the last couple of years the Profit Margin of 1SAN has grown nicely.
1SAN has a Operating Margin (23.59%) which is in line with its industry peers.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
1SAN has a Gross Margin (71.70%) which is comparable to the rest of the industry.
1SAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
1SAN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1SAN has about the same amount of shares outstanding.
Compared to 5 years ago, 1SAN has about the same amount of shares outstanding.
The debt/assets ratio for 1SAN has been reduced compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 2.21, which is a good value as it means it would take 1SAN, 2.21 years of fcf income to pay off all of its debts.
1SAN has a Debt to FCF ratio of 2.21. This is amongst the best in the industry. 1SAN outperforms 83.02% of its industry peers.
1SAN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
1SAN's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. 1SAN outperforms 75.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.8
WACC7.71%
2.3 Liquidity
A Current Ratio of 1.27 indicates that 1SAN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.27, 1SAN perfoms like the industry average, outperforming 47.17% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that 1SAN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, 1SAN is in line with its industry, outperforming 54.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
1SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.20%.
Measured over the past 5 years, 1SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
The Revenue has been growing slightly by 6.45% in the past year.
Measured over the past years, 1SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
3.2 Future
1SAN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.84% yearly.
Based on estimates for the next years, 1SAN will show a small growth in Revenue. The Revenue will grow by 4.46% on average per year.
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1SAN is valuated reasonably with a Price/Earnings ratio of 11.41.
Based on the Price/Earnings ratio, 1SAN is valued a bit cheaper than 79.25% of the companies in the same industry.
1SAN is valuated cheaply when we compare the Price/Earnings ratio to 27.42, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.93 indicates a reasonable valuation of 1SAN.
Based on the Price/Forward Earnings ratio, 1SAN is valued cheaper than 81.13% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. 1SAN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.41 | ||
| Fwd PE | 9.93 |
4.2 Price Multiples
1SAN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1SAN is cheaper than 60.38% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1SAN indicates a somewhat cheap valuation: 1SAN is cheaper than 60.38% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.84 | ||
| EV/EBITDA | 11.06 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.77
PEG (5Y)2.24
EPS Next 2Y6.3%
EPS Next 3Y6.57%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.54%, 1SAN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.00, 1SAN pays a better dividend. On top of this 1SAN pays more dividend than 88.68% of the companies listed in the same industry.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.54% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1SAN pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
BIT:1SAN (10/16/2025, 7:00:00 PM)
86.13
+2.09 (+2.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap209.90B
Analysts81.38
Price Target109.22 (26.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.54% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-0.49%
PT rev (3m)-2.85%
EPS NQ rev (1m)-3.87%
EPS NQ rev (3m)-9.35%
EPS NY rev (1m)0.21%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-1.51%
Revenue NQ rev (3m)-3.33%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-1.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.41 | ||
| Fwd PE | 9.93 | ||
| P/S | 3.09 | ||
| P/FCF | 20.84 | ||
| P/OCF | 18.44 | ||
| P/B | 3 | ||
| P/tB | 22.58 | ||
| EV/EBITDA | 11.06 |
EPS(TTM)7.55
EY8.77%
EPS(NY)8.68
Fwd EY10.07%
FCF(TTM)4.13
FCFY4.8%
OCF(TTM)4.67
OCFY5.42%
SpS27.86
BVpS28.73
TBVpS3.81
PEG (NY)2.77
PEG (5Y)2.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.71%
ROIC/WACC1.8
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y9.93%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%